Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer - Concepedia

Concepedia

Publication | Closed Access

Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer

1.3K

Citations

31

References

2008

Year

Navneet K. Dhillon, Bharat B. Aggarwal, Robert A. Newman, Robert A. Wolff, Ajaikumar B. Kunnumakkara, James L. Abbruzzese, Chaan S. Ng, Vladimir Badmaev, Razelle Kurzrock

Clinical Cancer Research

Abstract

Oral curcumin is well tolerated and, despite its limited absorption, has biological activity in some patients with pancreatic cancer.

References

	Year	Citations
New Guidelines to Evaluate the Response to Treatment in Solid Tumors Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer, JNCI Journal of the National Cancer Institute World Health OrganizationSolid TumorsCancer ManagementMetronomic ChemotherapyResponse Assessment	2000	15.7K
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. Howard A. Burris, Malcolm J. Moore, John Sahl Andersen, Journal of Clinical Oncology	1997	5.8K
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group Malcolm J. Moore, David Goldstein, John Hamm, Journal of Clinical Oncology	2007	3.8K
The use of the nitrogen mustards in the palliative treatment of carcinoma.With particular reference to bronchogenic carcinoma David A. Karnofsky, Walter H. Abelmann, Lloyd F. Craver, Cancer Palliative TreatmentMedicineNitrogen MustardsPathologyBronchial Neoplasm	1948	2.2K
Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Ann‐Lii Cheng, Chih‐Hung Hsu, Jen‐Kou Lin, PubMed Urinary Bladder CancerChemopreventive AgentOncologyChemoprevention StrategyOncogenic Agent	2001	2.1K
Activation of Transcription Factor NF-κB Is Suppressed by Curcumin (Diferuloylmethane) Sanjaya Singh, Bharat B. Aggarwal Journal of Biological Chemistry	1995	1.4K
Dose escalation of a curcuminoid formulation Christopher D. Lao, Mack T. Ruffin, Daniel P. Normolle, BMC Complementary and Alternative Medicine	2006	1.4K
Phase I Clinical Trial of Oral Curcumin Ricky A. Sharma, Stephanie A. Euden, Sharon L. Platton, Clinical Cancer Research	2004	1.2K
Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Ricky A. Sharma, Heather R. McLelland, K A Hill, PubMed OncologyChemoprevention StrategyGastrointestinal OncologyFood Bioactive CompoundGastrointestinal Pharmacology	2001	829
Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Olga Tucker, Andrew J. Dannenberg, Eun Kyung Yang, PubMed Cox-2 MrnaCyclooxygenase-2 ExpressionOncologyHuman PancreasGastrointestinal Oncology	1999	693

Page 1